With fresh approvals, mounting clinical evidence, and a surge in adoption by specialists far beyond endocrinology, these treatments are rewriting the rules for managing comorbid conditions and reshaping adjacent markets
In reality, these treatments are not aimed at rapid weight loss , but rather at a lasting change in the mechanisms of hunger and satiety
More recently, beta-amyloid was found to impair, but APOE4 itself to slightly improve, short-term memory among some 400 British participants without dementia (Lu et al., 2021)
Semaglutides patent protection in Canada expired in January 2026
Published studies show modest weight loss (39% body weight over 6 months), primarily through dietary behavior change and sustained engagement with the app interface